Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures... see more

GREY:ISOLF - Post Discussion

Isodiol International Inc > The halt is taking too long.
View:
Post by NotBornLastNite on Feb 03, 2021 1:20pm

The halt is taking too long.

If the halt  is connected to the civil claim, I grant them a grace period.  Otherwise, they should have by now aligned their ducks and reported financials.
Comment by yesiamgr8 on Feb 03, 2021 1:31pm
This post has been removed in accordance with Community Policy
Comment by NotBornLastNite on Feb 03, 2021 1:34pm
This is why... "In addition, and as a direct result of these delayed payments and continued impacts due to COVID-19, Isodiol has experienced delays in completing its previous Fiscal year-end audit and current fiscal year financial reporting requirements, resulting in a CTO trading halt of our stock in mid- December. Alvis states, "
Comment by NotBornLastNite on Feb 03, 2021 1:39pm
My thinking is they need Brain Bioceutical Corp resolution to satisfy IIROC.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities